Δευτέρα 1 Αυγούστου 2022

Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress

alexandrossfakianakis shared this article with you from Inoreader

41368_2022_193_Fig1_HTML.png

International Journal of Oral Science, Published online: 01 August 2022; doi:10.1038/s41368-022-00193-1

Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress
View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου